Skip to main content
. 2019 May 13;60(4):517–526. doi: 10.1093/jrr/rrz019

Table 2.

Comparison of the dose–volume indices of PTV60 and OARs between SIB-IMRT and 3DCRT

Dose index 3DCRT SIB-IMRT-D95% SIB-IMRT-D50% P-value
PTV60
 Volume (ml) (IQR) 138.8 (96.8, 188.1)
 D98% (Gy) (IQR) 54.3 (51.9, 56.1) 58.9 (57.8, 59.3) 53.7 (53.3, 54.0) <0.001
 D50% (Gy) (IQR) 60.4 (60.3, 61.0) 62.4 (61.9, 63.0) 60.1 (59.7, 60.3) <0.001
 D2% (Gy) (IQR) 63.5 (62.9, 63.7) 64.8 (64.5, 65.8) 63.1 (62.9, 63.7) <0.001
 HI (IQR) 0.135 (0.123, 0.182) 0.115 (0.086, 0.126) 0.155(0.150, 0.165) <0.001
 CN (IQR) 0.34 (0.32, 0.39) 0.77 (0.72, 0.79) 0.42 (0.36, 0.45) <0.001
Bilateral lungs
 Volume (ml) (IQR) 2866 (2591, 3366)
 V10Gy (%) (IQR) 23.3 (21.5, 26.3) 22.2 (20.2, 24.2) 21.3 (19.7, 24.2) 0.39
 V15Gy (%) (IQR) 17.7 (16.1, 21.7) 17.4 (15.5, 19.3) 16.9 (15.5, 18.2) 0.79
 V20Gy (%) (IQR) 12.6 (11.4, 15.3) 13.7 (12.3, 15.4) 13.4 (12.5, 14.4) 0.51
PRVcord
 Volume (ml) (IQR) 137.2 (127.1, 148.5)
 Maximum dose (Gy) (IQR) 49.5 (48.8, 49.9) 48.8 (48.4, 49.2) 49.2 (47.3, 51.2) 0.22
 D2 cm3 (Gy) (IQR) 46.6 (46.3, 47.2) 44.4 (43.9, 45.4) 45.2 (44.1, 46.8) <0.001
Thyroidout of PTV
 Volume (ml) (IQR) 6.6 (3.8, 7.7)
 V50Gy (%) (IQR) 100 (98.7, 100) 99.5 (98.5, 100) 100 (100, 100) 0.02
 V60Gy (%) (IQR) 74.7 (48.3, 79.0) 27.5 (16.4, 33.2) 29.2 (15.9, 48.2) 0.001
 Mean dose (Gy) (IQR) 60.5 (59.4, 61.0) 57.6 (56.3, 58.5) 58.4 (57.8,59.9) 0.007
Brachial plexus
 Volume (ml) (IQR) 6.6 (5.9, 8.6)
 V60Gy (ml) (IQR) 0 (0, 0) 0 (0, 0.05) 0 (0, 0) Not applicable
 D2 cm3 (Gy) (IQR) 49.4 (48.5, 50.4) 49.8 (48.8, 51.4) 51.3 (50.5, 52.7) 0.03
Vout of PTV
 Maximum dose (IQR) 64.6 (63.6, 65.1) 65.6 (64.0, 66.6) 64.0 (63.3, 64.7) 0.20
 D2 cm3 (IQR) 62.2 (61.8, 63.3) 62.6 (61.9, 63.3) 61.6 (61.1, 62.2) 0.25

3DCRT = 3D conformal radiotherapy, HI = homogeneity index [20], CN = conformity number [21], Dx cm3 = the dose covering x cm3 of the structure volume, Dx% = the dose covering x% of the structure volume, IQR = interquartile range, OARs = organs at risk, PRVcord = the planning organs-at-risk volume of spinal cord, PTV60 = the sum of the planning target volume of the primary tumor and the metastatic lymph nodes, SIB-IMRT = simultaneous integrated boost intensity-modulated radiotherapy, SIB-IMRT-D50%: SIB-IMRT with the prescribed dose of 60 Gy delivered to 50% of PTV60, SIB-IMRT-D95%: SIB-IMRT with the prescribed dose of 60 Gy delivered to 95% of PTV60, Thyroidout of PTV = volume of the thyroid gland excluding the volume overlapping with the PTV60, Vout of PTV = volume of the body out of all planning target volumes, Vx Gy = the volume receiving x Gy.